Bronchoalveolar lavage with pulmonary surfactant/dextran mixture improves meconium clearance and lung functions in experimental meconium aspiration syndrome

Almaas R, Robertson B, Linderholm B, Lundberg E, Saugstad OD, Moen A (2000) Reversal of meconium inhibition of pulmonary surfactant by ferric chloride, copper chloride, and acetic acid. Am J Respir Crit Care Med 162(5):1789–1794

Been JV, Zimmermann LJI (2007) What’s new in surfactant? A clinical view on recent developments in neonatology and paediatrics. Eur J Pediatr 166(9):889–899

Calkovska A, Some M, Linderholm B, Johansson J, Curstedt T, Robertson B (2005) Biophysical and physiological properties of porcine surfactant enriched with polymyxin B. Biol Neonate 88:101–108

Cochrane CG, Revak SD, Merritt TA, Schraufstatter IU, Hoch RC, Henderson C, Andreasson S, Takamori H, Oades ZG (1998) Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome. Pediatr Res 44:705–715

Cui XG, Tashiro K, Matsumoto H, Tsubokawa Y, Kobayashi T (2003) Aerosolized surfactant and dextran for experimental acute respiratory distress syndrome caused by acidified milk in rats. Acta Anaesthesiol Scand 47(7):853–860

Dargaville PA, Morley CJ (2000) Overcoming surfactant inhibition with polymers. Acta Paediatr 89:1397–1400

Dargaville PA, Mills JF, Headley BM, Chan Y, Coleman L, Loughnan PM, Morley CJ (2003) Therapeutic lung lavage in the piglet model of meconium aspiration syndrome. Am J Respir Crit Care Med 168(4):456–463

Dargaville PA, Mills JF (2005) Surfactant therapy for meconium aspiration syndrome: current status. Drugs 65:2569–2591

Findlay RD, Taeusch HW, Walther FJ (1996) Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 97:48–52

Greenough A (2000) Expanded use of surfactant replacement therapy. Eur J Pediatr 159(9):635–640

Kakinuma R, Shimizu H, Ogawa Y (2002) Effect of meconium on the rate of in vitro subtype conversion of swine pulmonary surfactant. Eur J Pediatr 161(1):31–36

Kobayashi T, Ohta K, Tashiro K, Nishizuka K, Chen W-M, Ohmura S, Yamamoto K (1999) Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract. J Appl Physiol 86(6):1778–1784

Lam BC, Yeung CY (1999) Surfactant lavage for meconium aspiration syndrome: a pilot study. Pediatrics 103:1014–1018

Lam BC, Yeung CY, Fu KH, Wong KY, Chan FL, Tsoi NS (2000) Surfactant tracheobronchial lavage for the management of a rabbit model of meconium aspiration syndrome. Biol Neonate 78:129–138

Lista G, Bianchi S, Castoldi F, Fontana P, Cavigioli F (2006) Bronchoalveolar lavage with diluted porcine surfactant in mechanically ventilated term infants with meconium aspiration syndrome. Clin Drug Investig 26(1):13–19

Lu KW, Taeusch HW, Robertson B, Goerke J, Clements JA (2000) Polymer-surfactant treatment of meconium-induced acute lung injury. Am J Respir Crit Care Med 162:623–628

Lu KW, Goerke J, Clements JA, Taeusch HW (2005) Hyaluronan reduces surfactant inhibition and improves rat lung function after meconium injury. Pediatr Res 58:206–210

Lu KW, Robertson B, Taeusch HW (2005) Dextran or polyethylene glycol added to Curosurf for treatment of meconium lung injury in rats. Biol Neonate 88(1):46–53

Meyuhas D, Nir S, Lichtenberg D (1996) Aggregation of phospholipid vesicles by water-soluble polymers. Biophys J 71:2602–2612

Moses D, Holm BA, Spitale P, Liu MY, Enhorning G (1991) Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol 164:477–481

Ochs M, Schüttler M, Stichtenoth G, Herting E (2006) Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran. Respir Res 7:86

Ohama Y, Ogawa Y (1999) Treatment of meconium aspiration syndrome with surfactant lavage in an experimental rabbit model. Pediatr Pulmonol 28(1):18–23

Rubin BK, Tomkiewicz RP, Patrinos ME, Easa D (1996) The surface and transport properties of meconium and reconstituted meconium solutions. Pediatr Res 40:834–838

Sevecova-Mokra D, Calkovska A, Drgova A, Javorka M, Javorka K (2004) Treatment of experimental meconium aspiration syndrome with surfactant lung lavage and conventional vs. asymmetric high-frequency jet ventilation. Pediatr Pulmonol 38:285–291

Stichtenoth G, Jung P, Walter G, Johansson J, Robertson B, Curstedt T, Herting E (2006) Polymyxin B/pulmonary surfactant mixtures have increased resistance to inactivation by meconium and reduce growth of gram-negative bacteria in vitro. Pediatr Res 59:407–411

Sun B, Curstedt T, Robertson B (1993) Surfactant inhibition in experimental meconium aspiration. Acta Paediatr 82(2):182–189

Sun B, Curstedt T, Robertson B (1996) Exogenous surfactant improves ventilation efficiency and alveolar expansion in rats with meconium aspiration. Am J Respir Crit Care Med 154:764–770

Sun B, Curstedt T, Lindgren G, Franzen B, Alaiya AA, Calkovska A, Robertson B (1997) Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A. Eur Resp J 10:1967–1974

Taeusch HW, Lu KW, Goerke J, Clements JA (1999) Nonionic polymers reverse inactivation of surfactant by meconium and other substances. Am J Respir Crit Care Med 159:1391–1395

Tashiro K, Kobayashi T, Robertson B (2000) Dextran reduces surfactant inhibition by meconium. Acta Paediatr 89:1439–1445

Tashiro K, Cui X-G, Kobayashi T, Curstedt T, Robertson B (2003) Modified protocols for surfactant therapy in experimental meconium aspiration syndrome. Biol Neonate 83(1):49–56

Weitzner JS, Strassner HT, Rawlins RG, Mack SR, Anderson RA (1990) Objective assessment of meconium content of amniotic fluid. Obstet Gynecol 76:1143–1144

Wiswell TE, Knight GR, Finer NN, Donn SM, Desai H, Walsh WF, Sekar KC, Bernstein G, Keszler M, Visser VE, Merritt TA, Mannino FL, Mastrioianni L, Marcy B, Revak SD, Tsai H, Cochrane CG (2002) A multicenter, randomized, controlled trial comparing Surfaxin (lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 109:1081–1087